Phase 1 Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of PRTX-100 in Healthy Adult Volunteers
PHASE1CompletedINTERVENTIONAL
Enrollment
20
Participants
Timeline
Start Date
June 30, 2007
Primary Completion Date
September 30, 2007
Study Completion Date
September 30, 2007
Conditions
Healthy Volunteers
Interventions
BIOLOGICAL
PRTX-100 (Staphylococcal protein A)
Trial Locations (1)
14202
Buffalo Clinical Research Center, Buffalo
All Listed Sponsors
lead
Protalex, Inc.
INDUSTRY
NCT00517855 - Phase 1 Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of PRTX-100 in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter